Distribution pattern of tenascin-C in normal and neoplastic mesenchymal tissues

International Journal of Cancer

Volumn 72, Issue 2, 1997, Pages 217-224

  Schnyder, Bruno ^a,b,c   Semadeni, Reto O ^b   Fischer, René W ^a   Vaughan, Lloyd ^a   Car, Bruce D ^a   Heitz, Philipp U ^b   Winterhalter, Kaspar H ^a   Odermatt, Bernhard F ^b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SCLEROPROTEIN; TENASCIN;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; EXTRACELLULAR MATRIX; GEL FILTRATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; LEIOMYOSARCOMA; MESENCHYME; MESENCHYMOMA; NEURILEMOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN LOCALIZATION; SOFT TISSUE TUMOR;

ANTIBODIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMOMA; MESODERM; PREGNANCY; TENASCIN;

EID: 0030834309     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970717)72:2<217::AID-IJC3>3.0.CO;2-U     Document Type: Article

References (24)

1. BORSI, L., ALLEMANNI, G., GAGGERO, B. and ZARDI, L., Extracellular pH controls pre-mRNA alternative splicing of tenascin-C in normal, but not in malignantly transformed, cells. Int. J. Cancer, 66, 632-635 (1996).
2. BORSI, L., CARNEMOLLA, B., NICOLO, G., SPINA, B., TANARA, G. and ZARDI, L., Expression of different tenascin isoforms in normal hyperplastic and neoplastic human breast tissues. Int. J. Cancer, 52, 688-692 (1992).
3. BROWN, M.T. and 14 OTHERS. Intrathecal I-131-labeled anti-tenascin-monoclonal-antibody-81C6 treatment of patients with leptomeningeal neoplasms or primary brain-tumor resection cavities with sub-arachnoid communication-phase-I trial results. Clin. Cancer Res., 2, 963-972 (1996).
4. DERYUGINA, E.I. and BOURDON, M.A., Tenascin mediates human gliomacell migration and modulates cell migration on fibronectin. J. Cell Science, 109, 643-652 (1996).
5. v integrins. Science, 270, 1500-1502 (1995).
6. GULCHER, J.R., NIES, D.E., MARTON, L.S. and STEFANSSON, K., An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc. nat. Acad. Sci. (Wash.), 86, 1588-1592 (1989).
7. HAUPTMANN, S., ZARDI, L., SIRI, A., CARNEMOLLA, B., BORSI, L., CASTELUCCI, M., KLOSTERHALFEN, S., HARTUNG, P., WEIS, J., STOECKER, G., HAUBECK, H-S. and KIRKPATRICK, J.C., Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab. Invest., 73, 172-182 (1995).
8. HIGUCHI, M., OHNISHI, T., ARITA, N., HIRAGA, S. and HAYAKAWA, T., Expression of tenascin in human gliomas: its relation to histological malignancy tumor de-differentiation and angiogenesis. Acta Neuropathol. (Berl.), 85, 481-487 (1993).
9. KAPLONY, A., ZIMMERMANN, D.R., FISCHER, R.W., IMHOF, B.A., ODERMATT, B.F., WINTERHALTER, K.H. and VAUGHAN, L., Tenascin Mr 220000 isoform expression correlates with corneal cell migration. Development, 112, 605-614 (1991).
10. LIGHTNER, V.A., GUMKOWSKI, F., BIGNER, D.D. and ERICKSON, H.P., Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy. J. Cell Biol., 108, 2483-2493 (1989).
11. MACKIE, E.J., CHIQUET-EHRISMANN, R., PEARSON, C.A., INAGUMA, Y., TAYA, K., KAWARADA, Y. and SAKAKURA, T., Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc. nat. Acad. Sci. (Wash.), 84, 4621-4625 (1987).
12. MARSHAL, B.C., SANTANA, A., XU, Q-P., PETERSEN, M.J., CAMPBELL, E.J., HOIDAL, J.R. and WELGUS, H.G., Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. J. clin. Invest., 91, 1792-1799 (1993).
13. MOCH, H., TORHORST, J., DURMUELLER, U., FEICHTER, G.E., SAUTER, G. and GUDAT, F., Comparative analysis of the expression of tenascin and established proanostic factors in human breast cancer. Pathol. Res. Pract., 189, 510-514 (1993).
14. NATALI, P.O., NICOTRA, M.R., BARTOLAZZI, A., MOTTOLESE, M., COSCIA, N., BIGOTTI, A. and ZARDI, L., Expression and production of tenascin in benign and malignant lesions of melanocyte lineage. Int. J. Cancer, 46, 586-590 (1990).
15. NATALI, P.O., NICOTRA, M.R., BIGOTTI, C., BOTTI, C., CASTELLANI, P., RISSO, A.M. and ZARDI, L., Comperative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal adult and tumor tissues. Int. J. Cancer, 47, 811-816 (1991).
16. NIES, D.E., HEMESATH, T.J., KIM, J.H., GULCHER, J.R. and STEFANSSON, K., The complete cDNA sequence of human hexabrachion. J. biol. Chem., 266, 2818-2823 (1991).
17. PRIETO, A.L., EDELMAN, G.M. and CROSSIN, K.L., Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc. nat. Acad. Sci. (Wash.), 90, 10154-10158 (1993).
18. RIEDL, S., BODENMUELLER, H., HINZ, U., HOLLE, R., MOELLER, P., SCHLAG, P., HERFARTH, C. and FAISSNER, A., Significance of tenascin serum level as tumor marker in primary colorectal carcinoma. Int. J. Cancer, 64, 65-69 (1995).
19. SAGA, Y., YAGI, T., IKAWA, Y., SAKAKURA, T. and AISAWA, S., Mice develop normally without tenascin. Genes Develop., 6, 1821-1831 (1992).
20. SASANO, H., NAGURA, H., WATANABE, K., ITO, K., TSUIKI, A., SATO, S., YAJIMA, A., KUSAKABE, M. and SAKAKURA, T., Tenascin expression in normal and abnormal human endometrium. Mod. Pathol., 6, 323-326 (1993).
21. SCHENK, S., MUSER, J., VOLLMER, G. and CHIQUET-EHRISMANN, R., Tenascin-C in serum: a questionable tumor marker. Int. J. Cancer, 61, 443-449 (1995).
22. c). Blood, 87, 4286-4295 (1996).
23. SPRING, J., BECK, K. and CHIQUET-EHRISMANN, R., Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell, 59, 325-334 (1989).
24. VAUGHAN, L., HUBER, S., CHIQUET, M. and WINTERHALTER, K.H., A major, six-armed glycoprotein from embryonic cartilage. EMBO J., 6, 349-353 (1987).